Collaboration in Manufacturing is Key to Improving Patient Access for Gene Therapy and Cell Therapy
June 15th 2023Betty Woo, the vice president and general manager of cell, gene, & advanced therapies at Thermo Fisher Scientific, discussed the challenges that exist in gene therapy and cell therapy manufacturing and potential solutions.
Reexamining the Outcome Measures Used in Ophthalmic Gene Therapy Trials
May 15th 2023Bart P. Leroy, MD, PhD, head of the Department of Ophthalmology at the Center for Medical Genetics of Ghent University Hospital, discussed the need to reevaluate the goal posts used to determine whether gene therapies for eye indications come to market.